NFE2L2 and esophageal squamous cell carcinoma: To examine the effects of ΔNp63α and NRF2 on ESCC progression, we generated xenograft models by subcutaneously injecting transfected ESCC cells into nude mice, followed by treatment with irradiation and ML385, an inhibitor of NRF2 (Fig. 6E).